ALPHARETTA, Ga. (AP) _ Alimera Sciences Inc. (ALIM) on Monday reported a loss of $5.3 million in its third quarter.
On a per-share basis, the Alpharetta, Georgia-based company said it had a loss of 75 cents.
The eye drug developer posted revenue of $13.6 million in the period.
The company's shares closed at $4.98. A year ago, they were trading at $6.11.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALIM at https://www.zacks.com/ap/ALIM